Navigation Links
ASA in Medical Technology

New Research Confirms the Benefit of Extended-Release Dipyridamole Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk Patients

Aggrenox® (Asasantin® Retard) considered by many as first-line in secondary stroke prevention INGELHEIM, Germany, 31 May 2007 - New data presented today at the 16th European Stroke Conference in Glasgow confirm that therapy with dipyridamole plus ASA (extended-release dipyridamole plus...

AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product

...with a three-fold higher risk of major CV events,(4A) which can occur within just 1-2 weeks of discontinuation.(4B) Up to 1 in 3 patients on low-dose asa may develop upper GI symptoms.(5A,6A) AstraZeneca conducted two studies to evaluate the safety and efficacy of NEXIUM in reducing the risk of gas...

Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer

...haradin to Treat Bone Metastases in Major Cancer Indications Algeta asa (OSE: ALGETA), the cancer therapeutics company, announces that with the res...ick on the ALSYPMCA link in the menu bar. About Algeta Algeta asa is a cancer therapeutics company built on world-leading, proprietary techno...

Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test

...rate Test's Potential for Rapid Uptake OSLO and FOSTER CITY, California, November 10 /PRNewswire-FirstCall/ -- DiaGenic asa (OSL: DIAG) and Applied Biosystems Inc. (NYSE: ABI ) today announced the launch of BCtect(TM), a blood-based test for early detection of breast cance...

Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting

... after the surgery. Therefore, modulating temperature becomes a very important tool in the physician's armamentarium. The cases being presented at the asa underscore the utility of temperature management for these situations." Various factors contribute to hypothermia during surgery, including the type...

Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin

...urvival of Patients With Hormone Refractory Prostate Cancer (HRPC) Algeta asa (OSE: ALGETA), the Norwegian cancer therapeutics company, today announced t... Research and the Royal Marsden Hospital in the UK. About Algeta Algeta asa is a Norwegian cancer therapeutics company built on world-leading, propriet...

Michael J. Fox Foundation Funds $1.1 Million for Cutting-Edge Approaches to Parkinson's Disease Under Rapid Response Innovation Awards 2008

... provided the head of their lab serves as administrative PI. Among the potentially high-impact Rapid Response projects funded so far this year: -- asa Abeliovich, MD, PhD, of Columbia University is working to determine whether a gene silencing technique using microRNAs -- short, noncoding molecules o...

Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents

...patients, with an average antiplatelet therapy duration of 12.5 days. After NCS, thienopyridine administration was not restarted and 100 mg per day of asa was the only cardiac antiplatelet therapy at discharge. MACE, including in-hospital cardiac death, MI, stent thrombosis, surgical bleeding complicatio...

Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy

...reversible neurological damage. MLD is caused by a deficiency in the enzyme asa which causes an excess concentration of sulphatide in cells and an ensuing ...tely 2,000 MLD patients in developed world markets(1). The newly acquired asa product, currently known as METAZYM(TM), has completed a Phase Ib clinical ...

Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program

...under of GeoVax Labs, Inc. She served as Chief of Microbiology and Immunology at Emory University's Yerkes National Primate Research Center and was an asa Griggs Candler Professor of Microbiology and Immunology at the Emory University School of Medicine. Dr. Robinson is a pioneer in DNA vaccines and on...

Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned

...e Japan, Plavix(R) has shown favourable tolerability profile as compared to asa and an acceptable increase in major bleedings when used in combination with asa (no statistical difference when only PCIs are considered). In Japan, Plavi...

Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia

...review by the EMEA was announced on July 20, 2007. The anticipated submissions for the U.S. and Japan are on schedule for later this year. During this asa annual meeting results from four additional Phase III trials were presented. About Organon Organon creates, manufactures and markets innovative pres...

MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study of Aquavan Injection in Patients Undergoing Bronchoscopy

...rate was 86.7% compared to 25.5% among patients treated with an initial bolus control dose of 2.0 mg/kg of Aquavan (p less than 0.001). Based upon the asa Physical Status Classification System, 31% of patients in this study were classified as P1 (having no known systemic disease), 65% were classified as ...

Viral Enzyme Recruited in Fight Against Ear Infection

...Fischetti. "This might truly be a case in which an ounce of prevention would be worth a pound of cure." Other St. Jude authors of this paper include asa Karlstrom and Amy R. Iverson (St. Jude). This work was supported in part by the United States Public Health Service and ALSAC. St. Jude Children's...

Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO

... OSLO, Norway, 30 May 2007 - Algeta asa (OSE: ALGETA), the Norwegian cancer therapeutics company, announces that Pr...rk.swallow@citigatedr.co.uk Citigate Dewe Rogerson About Algeta Algeta asa (www.algeta.com ) is a No...

Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood

...an 90Y-tiuxetan-ibritumomab (Zevalin) OSLO, Norway, 14 June 2007 - Algeta asa (OSE: ALGETA), the Norwegian cancer therapeutics company, announces that a ...rk.swallow@citigatedr.co.uk Citigate Dewe Rogerson About Algeta Algeta asa (www.algeta.com ) is a No...
Other Tags
(Date:2/9/2015)... -- Lintec of America recently announced an exclusive license to ... including sheets, yarns and ribbons, developed at the University ... vast industrial resources of the global Lintec Group, headquartered ... America is forming the Nano-Science and Technology Center (NSTC) ... scaling up the manufacturing and commercialization of nano engineered ...
(Date:2/5/2015)... 27, 2015   Marvin Test Solutions ... innovative test solutions for military, aerospace, and ... its TS-323 GENASYS Test Platform ... GENASYS is a high-performance PXI-based system designed ... that require performance functional testing. GENASYS features ...
(Date:2/5/2015)... VIEW, Calif. , Feb. 3, 2015 /PRNewswire/ ... printer technology, demand from industries such as consumer ... global market for surface mount technology (SMT) screen ... equipment to automatic control will push the adoption ... dispensers will remain steady as glue dispensers are ...
Breaking Biology News(10 mins):Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3
(Date:3/1/2015)... “ The Barrel Mill ” was featured on NewsWatch ... look at the latest and coolest technology products and services ... a technology expert, conducted the review and shared with viewers ... According to Home Distillation of Alcohol, it's understood that oak ... pretty cool product that’ll help anyone achieve a barrel aged ...
(Date:3/1/2015)... February 28, 2015 CrossFit Attollo is a ... are offering a special discount to new members. Now ... for a three month contract will receive their fourth month ... would cost members $440. The three month contract is ... and then the fourth month comes in at only $55. ...
(Date:2/28/2015)... In recent years Medical Marijuana has continuously ... as a way for them to expand their patient base ... medicine. Since the FDA still lists Cannabis as a Schedule ... licensed physicians that can help guide them when recommending ... in Santa Cruz, CA is a leader in the ...
(Date:2/28/2015)... February 28, 2015 In a recent ... of Game Change Athlete Development Services ... about the benefits of athlete development and player engagement ... the unique challenges that athletes face and how off-field ... success. , Fletcher became involved in athlete development issues ...
(Date:2/28/2015)... 2015 With their commitment to achieving ... an additional exercise to their already robust library of ... most commonly known as, is often performed on a ... executed in a relatively safe manner and can be ... The full description of “Rope Pulls” is located in ...
Breaking Medicine News(10 mins):Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3
Other Contents